Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASIPHAE: Palbociclib + Fulvestrant vs Capecitabine in Advanced Breast Cancer
NCT03322215Phase 2Terminated
- Start
- Oct 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of palbociclib in breast cancer. Started Oct 2017; status: terminated.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03322215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322215.